Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients (Q46288175)
Jump to navigation
Jump to search
scientific article published on 14 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients |
scientific article published on 14 May 2013 |
Statements
Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients (English)
Sarah Walter
Amos Baruch
Jin Dong
James E Tomlinson
Shawn T Alexander
Julie Janes
Tom Hunter
Qun Yin
Derek Maclean
Gregory Bell
Dirk B Mendel
Randolph M Johnson
Felix Karim
14 May 2013
346
2
229-240